Francesc Graus Selected Research

Cerebellar Ataxia (Dysmetria)

1/2020	Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2.
1/2020	Clinical significance of Kelch-like protein 11 antibodies.
1/2020	GAD antibodies in neurological disorders - insights and challenges.
10/2017	Antibody-associated CNS syndromes without signs of inflammation in the elderly.
11/2016	Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).
8/2015	Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
12/2014	Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.
8/2014	Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.
4/2013	Patient with homer-3 antibodies and cerebellitis.
1/2013	Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesc Graus Research Topics

Disease

44	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 08/2004
38	Neoplasms (Cancer) 11/2021 - 02/2003
17	Seizures (Absence Seizure) 01/2022 - 02/2003
17	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2021 - 05/2003
16	Autoimmune Diseases of the Nervous System 01/2021 - 01/2010
16	Cerebellar Ataxia (Dysmetria) 01/2020 - 10/2008
13	Paraneoplastic Cerebellar Degeneration 01/2019 - 01/2003
12	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019 - 03/2003
11	Multiple Sclerosis 11/2021 - 03/2003
10	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2021 - 03/2003
10	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2021 - 02/2013
10	Neuromyelitis Optica (Devic's Disease) 11/2019 - 09/2007
9	Brain Diseases (Brain Disorder) 01/2022 - 04/2003
9	Nervous System Diseases (Neurological Disorders) 01/2021 - 09/2012
8	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 01/2012
8	Ataxia (Dyssynergia) 08/2020 - 08/2004
8	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2020 - 05/2003
7	Leukocytosis (Pleocytosis) 01/2022 - 01/2013
7	Glioma (Gliomas) 01/2021 - 07/2005
6	Epilepsy (Aura) 09/2021 - 11/2014
6	Neurologic Manifestations (Neurological Manifestations) 12/2020 - 02/2003
5	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 10/2013
5	Thymoma (Thymic Carcinoma) 01/2021 - 12/2012
5	Autoimmune Diseases (Autoimmune Disease) 08/2020 - 05/2010
5	Optic Neuritis (Retrobulbar Neuritis) 01/2020 - 02/2015
5	Sleep Wake Disorders 11/2019 - 09/2014
5	Tauopathies 11/2019 - 06/2014
5	Lung Neoplasms (Lung Cancer) 04/2016 - 10/2003
5	Hodgkin Disease (Hodgkin's Disease) 04/2015 - 01/2003
4	Temporal Lobe Epilepsy 09/2021 - 11/2014
4	Myoclonus (Nocturnal Myoclonus) 01/2021 - 12/2011
4	Teratoma (Teratoid Tumor) 01/2020 - 12/2007
4	Cognitive Dysfunction 01/2020 - 05/2017
4	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 01/2019 - 07/2005
4	Disease Progression 01/2019 - 07/2003
4	Dementia (Dementias) 01/2018 - 04/2012
4	Herpes Simplex Encephalitis (Herpes Encephalitis) 01/2018 - 07/2013
4	Parasomnias (Parasomnia) 05/2017 - 06/2014
4	Lymphoma (Lymphomas) 05/2014 - 01/2002
3	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2020
3	Progressive Encephalomyelitis with Rigidity 01/2021 - 12/2011
3	Cerebellar Diseases (Cerebellar Syndrome) 12/2020 - 01/2003
3	Hypoventilation 01/2019 - 10/2007
3	Paraneoplastic Polyneuropathy 05/2018 - 01/2013
3	Glioblastoma (Glioblastoma Multiforme) 11/2017 - 07/2012
3	Isaacs Syndrome (Neuromyotonia) 03/2017 - 08/2010
3	Myelitis 03/2017 - 06/2015
3	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 04/2014 - 03/2002
3	Infections 01/2013 - 12/2004
3	Inflammation (Inflammations) 05/2012 - 05/2002
3	Narcolepsy 03/2007 - 08/2004
2	Movement Disorders (Movement Disorder) 08/2021 - 01/2019
2	Ovarian Teratoma 01/2020 - 04/2016
2	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2020 - 06/2015

Drug/Important Bio-Agent (IBA)

105	AntibodiesIBA 09/2021 - 03/2003
24	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 12/2007
23	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
19	AntigensIBA 01/2021 - 01/2003
19	AutoantibodiesIBA 01/2021 - 10/2008
18	Immunoglobulin G (IgG)IBA 01/2021 - 08/2003
10	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2021 - 10/2008
10	AutoantigensIBA 10/2013 - 01/2003
8	SteroidsIBA 03/2020 - 01/2007
7	Biomarkers (Surrogate Marker)IBA 08/2020 - 01/2015
7	Potassium Channels (Potassium Channel)IBA 04/2017 - 01/2006
7	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 06/2012 - 10/2003
6	EpitopesIBA 03/2020 - 01/2003
6	Surface Antigens (Surface Antigen)IBA 10/2017 - 05/2012
5	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2002
5	Glycine Receptors (Glycine Receptor)IBA 01/2021 - 04/2010
4	Pharmaceutical PreparationsIBA 01/2022 - 12/2004
4	Leucine (L-Leucine)FDA Link 01/2021 - 08/2010
4	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018 - 12/2007
4	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018 - 04/2013
3	Complement System Proteins (Complement)IBA 11/2021 - 10/2009
3	metabotropic glutamate receptor type 1IBA 12/2020 - 04/2010
3	AMPA Receptors (AMPA Receptor)IBA 01/2019 - 04/2009
3	Myelin-Oligodendrocyte GlycoproteinIBA 01/2019 - 02/2015
3	N-Methylaspartate (NMDA)IBA 01/2019 - 01/2014
3	1,3-dipropyl-8-phenylxanthineIBA 10/2017 - 01/2013
3	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 04/2017 - 01/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 01/2002
3	amphiphysinIBA 10/2013 - 05/2003
3	GABA-B ReceptorsIBA 12/2012 - 01/2010
3	OrexinsIBA 03/2007 - 08/2004
3	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2004 - 01/2002
2	Monoclonal AntibodiesIBA 01/2022 - 12/2017
2	Polytetrafluoroethylene (Teflon)FDA Link 01/2022 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 01/2018
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2021 - 04/2010
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 06/2012
2	AcidsIBA 01/2021 - 04/2011
2	Oligoclonal BandsIBA 08/2020 - 10/2008
2	anti-aquaporin 4 autoantibodyIBA 01/2020 - 06/2015
2	EnzymesIBA 12/2019 - 09/2009

Therapy/Procedure

20	Therapeutics 01/2022 - 03/2003
16	Immunotherapy 01/2022 - 10/2003
9	Radiotherapy 11/2019 - 01/2002
7	Drug Therapy (Chemotherapy) 11/2019 - 06/2004
2	Kidney Transplantation 11/2021 - 02/2014